Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H32N4O4S2 |
InChIKeyIIBZKDYAYJSSGB-UHFFFAOYSA-N |
CAS Registry845932-30-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | KN | 09 Jun 2013 | |
Neoplasms | Preclinical | NZ | 09 Jun 2013 |